Reversal of Acquired Drug Resistance in FLT3- Mutated Acute Myeloid Leukemia Cells via Distinct Drug Combination Strategies
![The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f5581abe-476c-4fa4-b2be-5fefacb34f48/gr1.jpg)
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet
![The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 - Annals of Oncology The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/39991385-0ed3-4307-a92d-d74f95b44992/gr1_lrg.jpg)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 - Annals of Oncology
![The careers of converts - how a transfer to BioMed Central affects the Impact Factors of established journals - Research in progress blog The careers of converts - how a transfer to BioMed Central affects the Impact Factors of established journals - Research in progress blog](https://blogs.biomedcentral.com/bmcblog/wp-content/uploads/sites/7/2014/01/Figure-2.png)
The careers of converts - how a transfer to BioMed Central affects the Impact Factors of established journals - Research in progress blog
![Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study - The Lancet Oncology Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/73d73a6c-9c0a-4da3-88a7-aa2facc7c080/gr1.jpg)
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study - The Lancet Oncology
![Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes | Nature Communications Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-28524-0/MediaObjects/41467_2022_28524_Fig1_HTML.png)
Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes | Nature Communications
![Factors influencing cancer patients' experiences of care in the USA, United Kingdom, and Canada: A systematic review - eClinicalMedicine Factors influencing cancer patients' experiences of care in the USA, United Kingdom, and Canada: A systematic review - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4ffaed53-99d8-4fbf-a21f-f8cbe66b24cf/gr1_lrg.jpg)